EXOSC8 antibody
Principal name
EXOSC8 antibody
Alternative names for EXOSC8 antibody
OIP2, RRP43,Exosome component 8, p9, Opa-interacting protein 2, Exosome complex exonuclease RRP43, Ribosomal RNA-processing protein 43
Ncbi ID
9606, NP_852480, NM_181503, NM_027148, NM_001163570, NP_852480.1
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of EXOSC8 antibody
- Kit Component:
- - KN204768G1, EXOSC8 gRNA vector 1 in pCas-Guide vector
- KN204768G2, EXOSC8 gRNA vector 2 in pCas-Guide vector
- KN204768D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Andersen JS. et al. (2005) Nature. 433:77–83Gerhard DS. et al. (2004) Gerhard DS. 14 : 2121–2127.
Immunoperoxidase of monoclonal antibody to EXOSC8 on formalin-fixed paraffin-embedded human placenta. [antibody concentration 3 ug/ml]
EXOSC8 monoclonal antibody (M01), clone 1G5 Western Blot analysis of EXOSC8 expression in HeLa NE ( Cat # L013V3 ).
Detection limit for recombinant GST tagged EXOSC8 is approximately 3ng/ml as a capture antibody.
Western blot analysis of anti-EXOSC8 Antibody (C-term) (Cat.#AP12431PU-N) in HL60 cell line lysates (35ug/lane). EXOSC8 (arrow) was detected using the purified Pab.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP12431PU-N | EXOSC8 (C-term) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP304768 | EXOSC8 |
||||
| Recombinant protein of human exosome component 8 (EXOSC8) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY405688 | EXOSC8 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216808L2V | Lenti ORF particles, Exosc8 (GFP-tagged) - Mouse exosome component 8 (Exosc8), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR203712L2V | Lenti ORF particles, Exosc8 (GFP-tagged) - Mouse exosome component 8 (Exosc8), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR216808L1V | Lenti ORF particles, Exosc8 (Myc-DDK-tagged) - Mouse exosome component 8 (Exosc8), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR203712L1V | Lenti ORF particles, Exosc8 (Myc-DDK-tagged) - Mouse exosome component 8 (Exosc8), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
